Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties - Zidovudine use to reduce perinatal HIV type-1 transmission in an urban medical center

被引：0
|
作者：
MacDonald, MG
机构：
来源：
PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT | 1996年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：434 / 435
页数：2
相关论文
共 50 条
  • [21] Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood
    Bhadrakom, C
    Simonds, RJ
    Mei, JV
    Asavapiriyanont, S
    Sangtaweesin, V
    Vanprapar, N
    Moore, KHP
    Young, NL
    Hannon, WH
    Mastro, TD
    Shaffer, N
    [J]. AIDS, 2000, 14 (05) : 509 - 516
  • [22] EFFICACY OF ANTENATAL ZIDOVUDINE IN REDUCING PERINATAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MATHESON, PB
    ABRAMS, EJ
    THOMAS, PA
    HERNAN, MA
    THEA, DM
    LAMBERT, G
    KRASINSKI, K
    BAMJI, M
    ROGERS, MF
    HEAGARTY, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02): : 353 - 358
  • [23] The Bangkok short-course zidovudine trial to reduce perinatal HIV transmission: summary of findings and operational issues
    Shaffer, N
    Chuachoowong, R
    Mock, PA
    Young, NL
    Neeyapun, K
    Jetsawang, B
    Naiwatanakul, T
    Mastro, TD
    Simonds, RJ
    [J]. PRENATAL AND NEONATAL MEDICINE, 1999, 4 (05): : 398 - 404
  • [24] Maternal-fetal transmission of HIV in southeastern Virginia: Impact of perinatal zidovudine (ZDV) use.
    Mitchell, DK
    Treichler, DB
    Dattel, BJ
    Rubio, TT
    [J]. PEDIATRIC RESEARCH, 1996, 39 (04) : 638 - 638
  • [25] Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced disease
    Bauer, GR
    Welles, SL
    Colgrove, RR
    Pitt, J
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) : 312 - 319
  • [26] Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: Effect of switching to didanosine or zidovudine plus didanosine therapy
    Principi, N
    Marchisio, P
    Esposito, S
    Rossi, P
    Gattinara, GC
    Galli, L
    Gabiano, C
    Zuccotti, GV
    Orlandi, P
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (18) : 1653 - 1659
  • [27] First reported use of zidovudine for prevention of perinatal HIV transmission in a premature neonate on extra corporal membrane oxygenation
    Emonts, Marieke
    Waalewijn, Hylke
    Colbers, Angela
    Pickering, Ailsa
    Burger, David
    [J]. AIDS, 2018, 32 (14) : 2084 - 2085
  • [28] Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission
    Giuliano, M
    Palmisano, L
    Galluzzo, CM
    Amici, R
    Germinario, E
    Okong, P
    Kituuka, P
    Mmirro, F
    Magoni, M
    Vella, S
    [J]. AIDS, 2003, 17 (10) : 1570 - 1572
  • [29] Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World
    Francis, DP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12): : 837 - 837
  • [30] Preventing perinatal transmission of HIV-1 infection
    Fiore, S
    Newell, ML
    [J]. HOSPITAL MEDICINE, 2000, 61 (05): : 315 - 318
12345